Novavax developing combination flu, COVID vaccine
US biotech firm Novavax on Monday said it had positive results from preclinical studies of a shot combining its influenza and COVID vaccine candidates.
by ·
US biotech firm Novavax on Monday said it had positive results from preclinical studies of a shot combining its influenza and COVID vaccine candidates.
by · Published May 8, 2021
by · Published May 4, 2021